Updated on 09 Nov 2026, 03:01 PM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,905.45 | -0.50 | 4,57,170.51 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 11,525.00 | 4.01 | 3,05,952.53 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,734.40 | -0.77 | 1,80,074.91 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,402.85 | -0.57 | 1,13,330.42 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,210.95 | 0.91 | 1,20,792.73 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-11-03 | Quarterly Results, Dividend and Other business matters |
| 2026-05-20 | Audited Results, Dividend & Others |
| 2025-11-10 | Quarterly Results & Interim Dividend |
| 2025-05-17 | Audited Results, Dividend & Others |
| 2024-11-09 | Quarterly Results & Interim Dividend |
Remus Pharmaceuticals is trading at 816.00 as on Mon Nov 09 2026 09:15:30. This is 0.12% upper as compared to its previous closing price of 839.80.
The market capitalization of Remus Pharmaceuticals is 961.57 Cr as on Mon Nov 09 2026 09:15:30.
The 52 wk high for Remus Pharmaceuticals is 1039.00 whereas the 52 wk low is 580.00
Remus Pharmaceuticals can be analyzed on the following key metrics -
Remus Pharmaceuticals reported a net profit of 36.99 Cr in 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.